InsiderDB
Sign inStart free trial

USAspending · Contract award

BSX: Department of Health and Human Services contract award

FLOXURIDINE FOR INJECTION 500MG/VIAL BOSTON SCIENTIFIC CORP:1105938 [26-006059]

Follow BSX
First observed
Nov 9, 2026, 9:57 AM EST
Event / period date
Aug 3, 2026
Collected
Nov 9, 2026, 9:57 AM EST

Why this is connected

Exact legal-name match: BOSTON SCIENTIFIC CORP (https://www.sec.gov/Archives/edgar/data/885725/).

Open the original source ↗Follow company activity in BSX

Reported contract amount

$38,907.00

Source last modified: Jul 29, 2026

Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.

Source evidence

Read the source excerpt or record
{"internal_id":360934612,"Award ID":"75N98026P01163","Recipient Name":"BOSTON SCIENTIFIC CORP","Award Amount":38907,"Description":"FLOXURIDINE FOR INJECTION 500MG/VIAL BOSTON SCIENTIFIC CORP:1105938 [26-006059]","Awarding Agency":"Department of Health and Human Services","Start Date":"2026-08-03","Last Modified Date":"2026-07-29 15:55:53","generated_internal_id":"CONT_AWD_75N98026P01163_7529_-NONE-_-NONE-","awarding_agency_id":806,"agency_slug":"department-of-health-and-human-services"}

Price change after we could observe it

+0.96% BSX

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in BSX

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.